Parabolic Drugs today said its net profit rose by 2.72% year-on-year to Rs 12.82 crore in the quarter ended December 31, 2011.
The company had posted a net profit of Rs 12.48 crore for the quarter ended December 31, 2010, Parabolic Drugs said in a filing to the BSE.
Total income of the company stood at Rs 273.57 crore during the quarter under review, as against Rs 151.47 crore for the corresponding period last fiscal.
During the third quarter this fiscal, the company started production of lifestyle drugs and non-antibiotics at its greenfield site in Lalru, Parabolic Drugs said.
Shares of Parabolic Drugs were being quoted at Rs 37.50 apiece in afternoon trade on the BSE today, up 1.35% from their previous close.